Open AccessIncrease in Body Mass Index in Children With HIV, Switched to Tenofovir Alafenamide Fumarate or Dolutegravir Containing Antiretroviral Regimens
Author(s) -
Daniel K Yeoh,
Anita J. Campbell,
Asha C Bowen
Publication year - 2021
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000003076
Subject(s) - dolutegravir , medicine , tenofovir alafenamide , abacavir , emtricitabine , tolerability , elvitegravir , cobicistat , regimen , rilpivirine , efavirenz , body mass index , lamivudine , pediatrics , viral load , adverse effect , human immunodeficiency virus (hiv) , virology , antiretroviral therapy , hepatitis b virus , virus